Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital.
Acinetobacter baumannii
Intensive Care Unit
Klebsiella pneumoniae
Multidrug resistance
Pseudomonas aeruginosa
Journal
Infection & chemotherapy
ISSN: 2093-2340
Titre abrégé: Infect Chemother
Pays: Korea (South)
ID NLM: 101531537
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
28
01
2021
accepted:
06
07
2021
pubmed:
12
9
2021
medline:
12
9
2021
entrez:
11
9
2021
Statut:
ppublish
Résumé
The members of the so-called ESKAPE group ( ESKAPE microorganisms were isolated from inpatients clinical samples. Bacterial identification, as well as antimicrobial susceptibility levels for up to 29 antimicrobial agents and presence of Extended-Spectrum β-Lactamases (only established in Of 9,918 clinical isolates, 1,917/3,777 (50.8%) [JAN/2009-JUN/2010 (Period 1)] and 4764/6141 (46.4%) [JAN/2012-DEC/2014 (Period 2)] belonged to the ESKAPE group ( The introduction of a successful extensively drug-resistant
Identifiants
pubmed: 34508324
pii: 53.e45
doi: 10.3947/ic.2021.0015
pmc: PMC8511375
doi:
Types de publication
Journal Article
Langues
eng
Pagination
449-462Subventions
Organisme : Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica
ID : 08-2019-FONDECYT-BM-INC-INV
Pays : Peru
Informations de copyright
Copyright © 2021 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.
Déclaration de conflit d'intérêts
No conflict of interest
Références
J Glob Antimicrob Resist. 2017 Dec;11:28-33
pubmed: 28743651
Int J Syst Evol Microbiol. 2017 Feb;67(2):502-504
pubmed: 27902205
J Travel Med. 2019 Dec 23;26(8):
pubmed: 31115466
J Infect Dev Ctries. 2020 Nov 30;14(11):1256-1263
pubmed: 33296338
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Eur J Clin Pharmacol. 2015 Jul;71(7):801-10
pubmed: 26008213
Am J Trop Med Hyg. 2016 Feb;94(2):285-8
pubmed: 26643537
Open Forum Infect Dis. 2019 Nov 22;6(12):ofz503
pubmed: 31844639
Rev Panam Salud Publica. 2020 Sep 23;44:e61
pubmed: 32973907
J Glob Antimicrob Resist. 2017 Jun;9:36-40
pubmed: 28219824
Int J Infect Dis. 2020 Jul;96:601-606
pubmed: 32505877
Int Microbiol. 2019 Mar;22(1):131-141
pubmed: 30810940
J Antimicrob Chemother. 2020 Jul 1;75(7):1840-1849
pubmed: 32277821
J Hosp Infect. 2021 Jan;107:114-115
pubmed: 33217492
BMC Pharmacol Toxicol. 2019 Apr 25;20(1):19
pubmed: 31023357
J Clin Microbiol. 2016 Oct;54(10):2436-47
pubmed: 27147728
J Med Microbiol. 2020 Jul;69(7):928-931
pubmed: 32584214
Infect Drug Resist. 2018 Oct 26;11:2021-2030
pubmed: 30464544
Braz J Infect Dis. 2017 May - Jun;21(3):343-348
pubmed: 28399424
Rev Peru Med Exp Salud Publica. 2017 Apr-Jun;34(2):261-267
pubmed: 29177386
Travel Med Infect Dis. 2018 Jan - Feb;21:28-35
pubmed: 29155322
Emerg Microbes Infect. 2018 Jul 4;7(1):119
pubmed: 29970918
Clin Microbiol Infect. 2018 Sep;24(9):964-969
pubmed: 29621616
Clin Infect Dis. 2009 Jan 1;48(1):1-12
pubmed: 19035777
Rev Peru Med Exp Salud Publica. 2018 Apr-Jun;35(2):259-264
pubmed: 30183920
Rev Peru Med Exp Salud Publica. 2016 Jun;33(2):215-23
pubmed: 27656919
Curr Microbiol. 2020 Nov;77(11):3264-3269
pubmed: 32785753
J Infect. 2012 Nov;65(5):406-11
pubmed: 22750236